Ronald Rooke

1.1k total citations
31 papers, 924 citations indexed

About

Ronald Rooke is a scholar working on Immunology, Virology and Infectious Diseases. According to data from OpenAlex, Ronald Rooke has authored 31 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 10 papers in Virology and 8 papers in Infectious Diseases. Recurrent topics in Ronald Rooke's work include Immunotherapy and Immune Responses (13 papers), HIV Research and Treatment (9 papers) and Virus-based gene therapy research (8 papers). Ronald Rooke is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), HIV Research and Treatment (9 papers) and Virus-based gene therapy research (8 papers). Ronald Rooke collaborates with scholars based in France, Canada and Switzerland. Ronald Rooke's co-authors include Diane Mathis, Christophe Benoıst, Caroline Waltzinger, Mark A. Wainberg, Naoko Nakano, Michel L. Tremblay, Xiaojian Yao, Hugo Soudeyns, Nathalie Accart and Mary M. Fanning and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and Immunity.

In The Last Decade

Ronald Rooke

30 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald Rooke France 14 462 270 258 191 175 31 924
Davor Frleta United States 12 491 1.1× 199 0.7× 74 0.3× 234 1.2× 227 1.3× 18 847
Weiduan Xu United States 6 410 0.9× 252 0.9× 116 0.4× 183 1.0× 170 1.0× 7 642
Mohammed Asmal United States 19 313 0.7× 246 0.9× 193 0.7× 578 3.0× 141 0.8× 41 1.1k
Davide Carlei Italy 11 260 0.6× 93 0.3× 133 0.5× 178 0.9× 400 2.3× 14 754
Raphaële Buser Switzerland 11 677 1.5× 366 1.4× 124 0.5× 262 1.4× 516 2.9× 11 1.2k
Rita de Giuli Switzerland 13 425 0.9× 200 0.7× 170 0.7× 556 2.9× 299 1.7× 16 1.1k
Catherine Blanc France 18 339 0.7× 243 0.9× 191 0.7× 149 0.8× 70 0.4× 39 756
Suresh de Silva United States 12 312 0.7× 288 1.1× 109 0.4× 187 1.0× 127 0.7× 23 579
Douglas A. Dedera United States 12 142 0.3× 225 0.8× 136 0.5× 419 2.2× 121 0.7× 14 776
Dominique Rebouillat France 17 511 1.1× 87 0.3× 119 0.5× 627 3.3× 160 0.9× 20 1.1k

Countries citing papers authored by Ronald Rooke

Since Specialization
Citations

This map shows the geographic impact of Ronald Rooke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Rooke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Rooke more than expected).

Fields of papers citing papers by Ronald Rooke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Rooke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Rooke. The network helps show where Ronald Rooke may publish in the future.

Co-authorship network of co-authors of Ronald Rooke

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Rooke. A scholar is included among the top collaborators of Ronald Rooke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Rooke. Ronald Rooke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lemonnier, François A., et al.. (2017). Identification of new MUC1 epitopes using HLA-transgenic animals: implication for immunomonitoring. Journal of Translational Medicine. 15(1). 154–154. 4 indexed citations
2.
Lanzardo, Stefania, Laura Conti, Ronald Rooke, et al.. (2015). Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer. Cancer Research. 76(1). 62–72. 103 indexed citations
3.
Rooke, Ronald. (2014). Can calcium signaling be harnessed for cancer immunotherapy?. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(10). 2334–2340. 7 indexed citations
4.
Accart, Nathalie, Mirjana Urosevic‐Maiwald, Reinhard Dummer, et al.. (2013). Lymphocytic infiltration in the cutaneous lymphoma microenvironment after injection of TG1042. Journal of Translational Medicine. 11(1). 226–226. 10 indexed citations
5.
Limacher, Jean‐Marc, et al.. (2013). Therapeutic cancer vaccines in the treatment of non-small-cell lung cancer. Expert Review of Vaccines. 12(3). 263–270. 6 indexed citations
6.
Bouziat, Romain, Michael Rasmussen, Francina Langa‐Vives, et al.. (2013). HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 Monochain Transgenic/H-2 Class I Null Mice: Novel Versatile Preclinical Models of Human T Cell Responses. The Journal of Immunology. 191(2). 583–593. 34 indexed citations
7.
Fend, Laetitia, Nathalie Accart, Jacqueline Kintz, et al.. (2013). Therapeutic Effects of Anti-CD115 Monoclonal Antibody in Mouse Cancer Models through Dual Inhibition of Tumor-Associated Macrophages and Osteoclasts. PLoS ONE. 8(9). e73310–e73310. 59 indexed citations
8.
Haegel, Hélène, Christine Thioudellet, Michel Geist, et al.. (2013). A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells. mAbs. 5(5). 736–747. 32 indexed citations
9.
Germain, Claire, Chantal Hoffmann, Nathalie Silvestre, et al.. (2013). Immunological Characterization of a Modified Vaccinia Virus Ankara Vector Expressing the Human Papillomavirus 16 E1 Protein. Clinical and Vaccine Immunology. 21(2). 147–155. 17 indexed citations
10.
Fend, Laetitia, Karola Rittner, Vanessa Duong, et al.. (2012). TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy. OncoImmunology. 1(8). 1271–1280. 13 indexed citations
11.
Rooke, Ronald, Christophe Benoıst, & Diane Mathis. (2003). Intrathymic Delivery of MHC Genes Using Recombinant Adenoviruses. Humana Press eBooks. 134. 69–79. 3 indexed citations
12.
Bock, David C., et al.. (2003). Controlled plasmid gene transfer to murine renal carcinoma by hexadecylphosphocholine. Journal of Controlled Release. 94(1). 237–244. 5 indexed citations
13.
Paul, Stéphane, Etienne Régulier, Ronald Rooke, et al.. (2002). Tumor gene therapy by MVA-mediated expression of T-cell–stimulating antibodies. Cancer Gene Therapy. 9(5). 470–477. 19 indexed citations
14.
15.
Rooke, Ronald, Caroline Waltzinger, Christophe Benoıst, & Diane Mathis. (1997). Targeted Complementation of MHC Class II Deficiency by Intrathymic Delivery of Recombinant Adenoviruses. Immunity. 7(1). 123–134. 186 indexed citations
16.
Tremblay, Michel L., Ronald Rooke, & Mark A. Wainberg. (1992). Zidovudine-resistant and -sensitive HIV-1 isolates from patients on drug therapy. AIDS. 6(12). 1445–1450. 7 indexed citations
17.
Rooke, Ronald, et al.. (1991). Isolement de souches HIV-1 résistantes à l'AZT : limites des analogues de nucléosides dans la chimiothérapie du SIDA. médecine/sciences. 7(2). 118–118. 2 indexed citations
18.
Wainberg, Mark A., Michel L. Tremblay, Ronald Rooke, et al.. (1990). Characterization of Reverse Transcriptase Activity and Susceptibility to Other Nucleosides of AZT‐Resistant Variants of HIV‐1. Annals of the New York Academy of Sciences. 616(1). 346–355. 17 indexed citations
19.
Tremblay, Michel L., Ronald Rooke, Romas Geleziunas, et al.. (1989). New cd4( +) cell line susceptible to infection by hiv‐1. Journal of Medical Virology. 28(4). 243–249. 16 indexed citations
20.
Rooke, Ronald, Hugo Soudeyns, Xiaojian Yao, et al.. (1989). Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy. AIDS. 3(7). 411–416. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Davor Frleta Breakdown of academic impact, for papers by Weiduan Xu Breakdown of academic impact, for papers by Mohammed Asmal Breakdown of academic impact, for papers by Davide Carlei Breakdown of academic impact, for papers by Raphaële Buser Breakdown of academic impact, for papers by Rita de Giuli Breakdown of academic impact, for papers by Catherine Blanc Breakdown of academic impact, for papers by Suresh de Silva Breakdown of academic impact, for papers by Douglas A. Dedera Breakdown of academic impact, for papers by Dominique Rebouillat
Rankless by CCL
2026